Trade Summary

3 days ago, Krainer Adrian R., serving as Dir at Stoke Therapeutics, Inc. (STOK), sold 7,229 shares at $39.66 per share, for a total transaction value of $286,715.00. Following this transaction, Krainer Adrian R. now holds 316,545 shares of STOK.

This sale represents a 2.00% decrease in Krainer Adrian R.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Stoke Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.